medigraphic.com
ISSN 2007-6800 (Impreso)

2016, Número 3

<< Anterior Siguiente >>

Rev Mex Traspl 2016; 5 (3)


Trasplante de donador a corazón parado

Lammel-Lindemann JA, García-Alonso MJ, Flores-Villalba E

Idioma: Español
Referencias bibliográficas: 34
Paginas: 120-124
Archivo PDF: 224.28 Kb.


RESUMEN

El uso de órganos provenientes de donadores a corazón parado puede aumentar sustancialmente la cantidad de órganos destinados a trasplantes. Otros países han demostrado resultados prometedores. Los lineamientos generales para este tipo de pacientes, aunados a la existencia de situaciones como el fenómeno de Lázaro y la regla del donador fallecido con sus respectivos tiempos de espera y afectaciones, son diferentes e implican aspectos éticos y legales que deben ser respetados y llevados al pie de la letra con decisiones objetivas y sin sesgos. Es de suma importancia respetar los límites de isquemia propuestos para cada órgano, el tiempo desde el retiro de soporte vital e intentar minimizar los tiempos de isquemia lo más posible, así como el uso de máquinas de perfusión y algunos medicamentos que permitan reducir al máximo el daño al órgano a trasplantar.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Blackstock MJ, Ray DC. Organ donation after circulatory death: an update. Eur J Emerg Med. 2014; 21 (5): 324-329.

  2. Barry JM, Murray JE. The first human renal transplants. J Urol. 2006; 176 (3): 888-890.

  3. Starzl TE, Groth CG, Brettschneider L, Penn I, Fulginiti VA, Moon JB et al. Orthotopic homotransplantation of the human liver. Ann Surg. 1968; 168 (3): 392-415.

  4. Calne RY, Rolles K, White DJ, Thiru S, Evans DB, McMaster P et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet. 1979; 2 (8151):1033-1036.

  5. Starzl TE, Klintmalm GB, Porter KA, Iwatsuki S, Schröter GPJ. Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med. 1981; 305 (5): 266-269.

  6. Abt PL, Fisher CA, Singhal AK. Donation after cardiac death in the US: history and use. J Am Coll Surg. 2006; 203 (2): 208-225.

  7. A definition of irreversible coma: report of the ad hoc committee of the Harvard Medical School to examine the definition of brain death. JAMA. 1968; 205 (6): 337-340.

  8. Diagnosis of brain death. Statement issued by the Honorary Secretary of the Conference of Medical Royal Colleges and their Faculties in the United Kingdom on 11th October 1976 Ann R Coll Surg Engl. 1977; 59 (2): 170-172.

  9. Dib-Kuri A, Aburto-Morales S, Espinosa-Álvarez A, Sánchez-Ramírez O. Trasplante de órganos y tejidos en México. Rev Investig Clínica. 2005; 57 (2): 163-169.

  10. Orozco-Zepeda H. Un poco de historia sobre el trasplante hepático. Rev Investig Clínica. 2005; 57 (2): 124-128.

  11. Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors. Transplant Proc. 1995; 27 (5): 2893-2894.

  12. Truog RD, Miller FG, Halpern SD. The dead-donor rule and the future of organ donation. N Engl J Med. 2013; 369 (14): 1287-1289.

  13. Adhiyaman V, Adhiyaman S, Sundaram R. The Lazarus phenomenon. J R Soc Med. 2007; 100 (12): 552-557.

  14. Joffe AR, Carcillo J, Anton N, deCaen A, Han YY, Bell MJ et al. Donation after cardiocirculatory death: a call for a moratorium pending full public disclosure and fully informed consent. Philos Ethics Humanit Med. 2011; 6: 17.

  15. Halazun KJ, Al-Mukhtar A, Aldouri A, Willis S, Ahmad N. Warm ischemia in transplantation: search for a consensus definition. Transplant Proc. 2007; 39 (5): 1329-1331.

  16. Cota N, Burgess M, English W. Organ donation after circulatory death anaesthesia tutorial of the week. 2013; 282.

  17. Moers C, Pirenne J, Paul A, Ploeg RJ. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med. 2012; 366 (8): 770-771.

  18. Weeder PD, van Rijn R, Porte RJ. Machine perfusion in liver transplantation as a tool to prevent non-anastomotic biliary strictures: rationale, current evidence and future directions. J Hepatol. 2015; 63 (1): 265-275.

  19. Fondevila C, Hessheimer AJ, Maathuis M-HJ, Muñoz J, Taurá P, Calatayud D et al. Hypothermic oxygenated machine perfusion in porcine donation after circulatory determination of death liver transplant. Transplantation. 2012; 94 (1): 22-29.

  20. Guarrera JV, Henry SD, Samstein B, Odeh-Ramadan R, Kinkhabwala M, Goldstein MJ et al. Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant. 2010; 10 (2): 372-381.

  21. Guarrera JV, Henry SD, Samstein B, Reznik E, Musat C, Lukose TI et al. Hypothermic machine preservation facilitates successful transplantation of “orphan” extended criteria donor livers. Am J Transplant. 2015; 15 (1): 161-169.

  22. Snoeijs MGJ, Winkens B, Heemskerk MBA, Hoitsma AJ, Christiaans MHL, Buurman WA et al. Kidney transplantation from donors after cardiac death: a 25-year experience. Transplantation. 2010; 90 (10): 1106-1112.

  23. Gagandeep S, Matsuoka L, Mateo R, Cho YW, Genyk Y, Sher L et al. Expanding the donor kidney pool: utility of renal allografts procured in a setting of uncontrolled cardiac death. Am J Transplant. 2006; 6 (7): 1682-1688.

  24. Snoeijs MG, Schaubel DE, Hené R, Hoitsma AJ, Idu MM, Ijzermans JN et al. Kidneys from donors after cardiac death provide survival benefit. J Am Soc Nephrol. 2010; 21 (6): 1015-1021.

  25. Domagala P, Kwiatkowski A, Perkowska-Ptasinska A, Wszola M, Panufnik L, Paczek L et al. Assessment of kidneys procured from expanded criteria donors before transplantation. Transplant Proc. 2009; 41 (8): 2966-2969.

  26. Rudich SM, Kaplan B, Magee JC, Arenas JD, Punch JD, Kayler LK et al. Renal transplantations performed using non-heart-beating organ donors: going back to the future? Transplantation. 2002; 74 (12): 1715-1720.

  27. Weber M, Dindo D, Demartines N, Ambühl PM, Clavien P-A. Kidney transplantation from donors without a heartbeat. N Engl J Med. 2002; 347 (4): 248-255.

  28. Jay CL, Lyuksemburg V, Ladner DP, Wang E, Caicedo JC, Holl JL et al. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Ann Surg. 2011; 253 (2): 259-264.

  29. Abt PL, Desai NM, Crawford MD, Forman LM, Markmann JW, Olthoff KM et al. Survival following liver transplantation from non-heart-beating donors. Ann Surg. 2004; 239 (1): 87-92.

  30. De Oliveira NC, Osaki S, Maloney JD, Meyer KC, Kohmoto T, D’Alessandro AM et al. Lung transplantation with donation after cardiac death donors: long-term follow-up in a single center. J Thorac Cardiovasc Surg. 2010; 139 (5): 1306-1315.

  31. Levvey B, Harkess M, Chambers D, Granger E, Ahmed I, Hopkins P et al. 351: Are DCD Lungs Superior? Excellent intermediate results from a donation after cardiac death lung transplant national collaborative. J Heart Lung Transplant. 2010; 29 (2): S117-118.

  32. De Vleeschauwer SI, Wauters S, Dupont LJ, Verleden SE, Willems-Widyastuti A, Vanaudenaerde BM et al. Medium-term outcome after lung transplantation is comparable between brain-dead and cardiac-dead donors. J Heart Lung Transplant. 2011; 30 (9): 975-981.

  33. Wauters S, Verleden GM, Belmans A, Coosemans W, De Leyn P, Nafteux P et al. Donor cause of brain death and related time intervals: does it affect outcome after lung transplantation? Eur J Cardio-Thorac Surg. 2011; 39 (4): e68-76.

  34. Wigfield CH, Love RB. Donation after cardiac death lung transplantation outcomes. Curr Opin Organ Transplant. 2011; 16 (5): 462-468




2020     |     www.medigraphic.com